Correction to: Scientific Reports https://doi.org/10.1038/s41598-025-97775-w, published online 19 April 2025

The original version of this Article contained an error where an incorrect version of Fig. 9 was published. Specifically, Panels B and F inadvertently display H&E images from a different experimental group than indicated and the magnification across panels is inconsistent.

The original Fig. 9 and accompanying legend appear below.

Fig. 9
figure 9

Prussian blue iron stains of GBM39 tumors after theranostic therapy. (A,C,E) Representative Prussian blue (PB) stained tumor sections from the combination therapy group, monotherapy group, and control group at 48 h after intravenous injections. Scale bar: 100 μm; magnification: × 20. (G) Quantitative analysis of Prussian blue-positive staining area. Box plots illustrate the proportion of positively stained areas relative to the total tumor area (%) for each group (n = 4 mice in each group). Statistical comparison of PB-positive staining between the combination therapy group and monotherapy group was performed using the Mann–Whitney U test. The control group showed no detectable PB staining and was excluded from statistical analysis. (B,D,F) Representative hematoxylin and eosin (H&E) stained tumor sections from the combination therapy, monotherapy, and control groups, respectively. We did not observe any significant intra-tumoral hemorrhage in response to TNP treatment.

The original Article has been corrected.